Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI System Accurately Detects Lung Cancer in CT Scans

By HospiMedica International staff writers
Posted on 05 Sep 2018
Engineers from the University of Central Florida's Computer Vision Research Center (Orlando, FL, USA) have developed an artificial intelligence (AI) system which can detect tiny specks of lung cancer in CT scans. More...
Radiologists find it difficult to identify such tiny tumors and have an accuracy of 65%, while the AI system has an accuracy of about 95%, according to the engineers.

In order to teach the computer to look for the tumors, the scientists fed more than 1,000 CT scans into the software and used the same kind of algorithms, which are utilized by facial-recognition software to scan thousands of faces in search of a particular pattern and find a match. The computer was taught to ignore other tissue, nerves and other masses found in the CT scans and analyze lung tissues.

"We used the brain as a model to create our system," said Rodney LaLonde, a doctoral candidate. "You know how connections between neurons in the brain strengthen during development and learn? We used that blueprint, if you will, to help our system understand how to look for patterns in the CT scans and teach itself how to find these tiny tumors."

The researchers are now fine-tuning the AI's ability to identify cancerous versus benign tumors and also study if they can develop another AI system to help identify or predict brain disorders.

"I believe this will have a very big impact," said engineering assistant professor Ulas Bagci who led the group of researchers at the center, which focuses on AI with potential medical applications. "Lung cancer is the number one cancer killer in the United States and if detected in late stages, the survival rate is only 17%. By finding ways to help identify earlier, I think we can help increase survival rates."

Related Links:
University of Central Florida Computer Vision Research Center


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.